J&J To Seek Remicade Rights Amid Pending Schering-Plough/Merck Merger
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck and Schering argue the merger does not constitute “change of control” for Remicade and Simponi under initial J&J agreement.